Warp Sciences
US chemistry contract research organization that combines medicinal chemists, AI and lab robotics to make research compounds for biotech and pharma drug discovery teams.
Warp Sciences has raised $215M across 1 disclosed round since Oct 22, 2026; the latest round, Series A, was announced on Oct 22, 2026. Data as of Oct 23, 2026.
Headquartered in United States.
Latest from MEKAWIRE
Funding history
| Date | Round | Amount | Post-money valuation | Lead investor | Investors | Status | Source |
|---|---|---|---|---|---|---|---|
| Oct 22, 2026 | Series A | $215M | — | Lightspeed Venture Partners | Lightspeed Venture PartnersPremji InvestMayfieldIVPLux CapitalConvictionMenlo Ventures01 AdvisorsStandardLowercarbon CapitalGigascale CapitalAngular VenturesScribble VenturesUncork CapitalInnovation EndeavorsMatter Venture PartnersZero Shot FundSignalFireMoxxie Ventures | Official | Source |